LATE-PASSAGE SC-1 CELLS RESISTANT TO N- AND B-TROPIC VIRUSES BUT SENSITIVE TO NB-TROPIC VIRUSESPINCUS T.1980; J. VIROL.; USA; DA. 1980; VOL. 34; NO 3; PP. 711-715; BIBL. 15 REF.Article

EVIDENCE THAT ENDOGENOUS ECOTROPIC VIRUS IS NOT EXPRESSED IN AKR THYMIC LYMPHOID CELLS OF CHIMERIC HOSTSBLANK KJ; PINCUS T.1980; J. EXPER. MED.; USA; DA. 1980; VOL. 152; NO 2; PART. 1; PP. 458-462; BIBL. 19 REF.Article

Radiological deterioration worsens despite clinical improvement in rheumatoid arthritisPINCUS, T.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 3, issn 0392-856X, p. 279Article

Documenting quality management in rheumatic disease : Are patient questionnaires the best (and only) method ?PINCUS, T.Arthritis care and research. 1996, Vol 9, Num 5, pp 339-348, issn 0893-7524Article

Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseasesPINCUS, T.Seminars in arthritis and rheumatism. 1993, Vol 23, Num 2, pp 2-10, issn 0049-0172, SUP1Article

The case for early intervention in rheumatoid arthritisPINCUS, T.Journal of autoimmunity (Print). 1992, Vol 5, pp 209-226, issn 0896-8411, SUPAConference Paper

Assessing psychological factors in chronic pain : a new approachPINCUS, T.Physical therapy reviews. 1998, Vol 3, Num 1, pp 41-45, issn 1083-3196Article

The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritisPINCUS, T.Seminars in arthritis and rheumatism. 1992, Vol 21, Num 6, pp 2-15, issn 0049-0172, SUP3Article

Should an order to monitor long-term vital signs, including mortality outcomes, be as routine as an order for a laboratory test in patients with rheumatic diseases?PINCUS, T; SOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2008, Vol 26, Num 5, issn 0392-856X, S21-S24, SUP51Article

An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United StatesSOKKA, T; PINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S178-S181, issn 0392-856X, SUP39Article

Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical carePINCUS, T; SOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S1-S9, issn 0392-856X, SUP39Article

Rheumatology function tests : Quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseasesPINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S85-S89, issn 0392-856X, SUP39Article

The American College of Rheumatology (ACR) Core Data set and derivative patient only indices to assess rheumatoid arthritisPINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S109-S113, issn 0392-856X, SUP39Article

A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA) : Efficient capture of essential data for clinical trials and observational studiesPINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S114-S119, issn 0392-856X, SUP39Article

Quantitative joint assessment in rheumatoid arthritisSOKKA, T; PINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S58-S62, issn 0392-856X, SUP39Article

POLYMORPHISM OF ENDOGENOUS MURINE LEUKEMIA VIRUSES REVEALED BY ISOELECTRIC FOCUSING IN POLYACRYLAMIDE GELS.PFEFFER L; PINCUS T; FLEISSNER E et al.1976; VIROLOGY; U.S.A.; DA. 1976; VOL. 74; NO 1; PP. 273-276; BIBL. 28 REF.Article

VARIATION IN RNA TUMOR VIRUS EXPRESSION IN H-2 CONGENIC LEUKEMIA CELL LINESWOLFE JH; BLANK KJ; PINCUS T et al.1981; IMMUNOGENETICS (N. Y.); ISSN 0093-7711; DEU; DA. 1981; VOL. 12; NO 1-2; PP. 187-190; BIBL. 18 REF.Article

EVIDENCE THAT RETROVIRUS EXPRESSION IN MOUSE SPLEEN CELLS RESULTS FROM B CELL DIFFERENTIATIONALBERTO BP; CALLAHAN LF; PINCUS T et al.1982; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1982; VOL. 129; NO 6; PP. 2768-2772; BIBL. 38 REF.Article

MULTIPLICITY-DEPENDENT KINETICS OF MURINE LEUKEMIA VIRUS INFECTION IN FV-1-SENSITIVE AND FV-1-RESISTANT CELLS.O'DONNELL PV; DEITCH CJ; PINCUS T et al.1976; VIROLOGY; U.S.A.; DA. 1976; VOL. 73; NO 1; PP. 23-35; BIBL. 1 P. 1/2Article

SPECIFICITIES OF HUMAN IMMUNOGLOBULINS REACTIVE WITH ANTIGENS IN PREPARATIONS OF SEVERAL MAMMALIAN TYPE-C VIRUSES.SNYDER HW JR; PINCUS T; FLEISSNER E et al.1976; VIROLOGY; U.S.A.; DA. 1976; VOL. 75; NO 1; PP. 60-73; BIBL. 2 P.Article

RETROVIRUS PURIFICATION: METHOD THAT CONSERVES ENVELOPE GLYCOPROTEIN AND MAXIMIZES INFECTIVITY.MCGRATH M; WITTE O; PINCUS T et al.1978; J. VIROL.; U.S.A.; DA. 1978; VOL. 25; NO 3; PP. 923-927; BIBL. 14 REF.Article

REDUCED T-LYMPHOCYTE SUBSETS IN SYSTEMIC LUPUS ERYTHEMATOSUS: EFFECTS OF IMMUNE COMPLEXES AND LYMPHOCYTOTOXIC ANTIBODIESDEHORATIUS RJ; TUNG KSK; PINCUS T et al.1980; CLIN. IMMUNOL. IMMUNOPATHOL.; ISSN 0090-1229; USA; DA. 1980; VOL. 17; NO 2; PP. 245-256; BIBL. 37 REF.Article

A MAJOR GENETIC LOCUS AFFECTING RESISTANCE TO INFECTION WITH MURINE LEUKEMIA VIRUSES. IV. DOSE-RESPONSE RELATIONSHIPS IN FV-1-SENSITIVE AND RESISTANT CELL CULTURES = UN LOCUS GENETIQUE MAJEUR AFFECTANT LA RESISTANCE A L'INFECTION PAR LES VIRUS DE LEUCEMIE MURINE. IV. RELATIONS DOSE-REPONSE DANS DES CULTURES CELLULAIRES RESISTANTES ET SENSIBLES FV-1PINCUS T; HARTLEY JW; ROWE WP et al.1975; VIROLOGY; U.S.A.; DA. 1975; VOL. 65; NO 2; PP. 333-342; BIBL. 22REF.Article

Limitations of a biomedical model to explain socioeconomic disparities in mortality of rheumatic and cardiovascular diseasesABELSON, B; RUPEL, A; PINCUS, T et al.Clinical and experimental rheumatology (Testo stampato). 2008, Vol 26, Num 5, issn 0392-856X, S25-S34, SUP51Article

Mortality in rheumatoid arthritis : 2008 updateSOKKA, T; ABELSON, B; PINCUS, T et al.Clinical and experimental rheumatology (Testo stampato). 2008, Vol 26, Num 5, issn 0392-856X, S35-S61, SUP51Article